Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance

Publisher： Karger

E-ISSN： 1421-9875|31|5-6|421-425

ISSN： 0257-2753

Source： Digestive Diseases, Vol.31, Iss.5-6, 2013-11, pp. : 421-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Viral Kinetics and Treatment Response in Patients with Hepatitis C During Induction and Standard Interferon Therapy in Combination with Ribavirin

By Carlsson T.   Weiland O.   Reichard O.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1228-1234

Informa Healthcare

Access to resources Recommend Favorite

Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy

By  

Digestion, Vol. 84, Iss. 1, 2011-12 ,pp. : 56-61

Karger

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C with High Viral Load of Serum Hepatitis C Virus RNA, Genotype 1b, Discontinued on Attaining Sustained Virological Response at Week 16 after Onset of Acute Pancreatitis

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 36-39

Karger

Access to resources Recommend Favorite